nodes	percent_of_prediction	percent_of_DWPC	metapath
Antazoline—HRH1—Ketotifen—asthma	0.499	0.587	CbGbCtD
Antazoline—HRH1—Loratadine—asthma	0.351	0.413	CbGbCtD
Antazoline—HRH1—nose—asthma	0.0265	0.628	CbGeAlD
Antazoline—HRH1—respiratory system—asthma	0.00347	0.0823	CbGeAlD
Antazoline—HRH1—epithelium—asthma	0.0029	0.0688	CbGeAlD
Antazoline—HRH1—smooth muscle tissue—asthma	0.0028	0.0663	CbGeAlD
Antazoline—HRH1—trachea—asthma	0.00257	0.0608	CbGeAlD
Antazoline—HRH1—adrenal gland—asthma	0.0021	0.0499	CbGeAlD
Antazoline—HRH1—lung—asthma	0.00184	0.0437	CbGeAlD
Antazoline—HRH1—GPCRs, Class A Rhodopsin-like—CCR3—asthma	0.00042	0.0039	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—CCL17—asthma	0.000417	0.00387	CbGpPWpGaD
Antazoline—HRH1—G alpha (q) signalling events—KNG1—asthma	0.000395	0.00367	CbGpPWpGaD
Antazoline—HRH1—GPCRs, Class A Rhodopsin-like—AGTR2—asthma	0.000395	0.00367	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—C5—asthma	0.000393	0.00365	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—TACR1—asthma	0.000393	0.00365	CbGpPWpGaD
Antazoline—HRH1—G alpha (q) signalling events—AGTR1—asthma	0.000393	0.00365	CbGpPWpGaD
Antazoline—HRH1—IL-4 Signaling Pathway—STAT3—asthma	0.000391	0.00363	CbGpPWpGaD
Antazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—BDKRB2—asthma	0.000388	0.00361	CbGpPWpGaD
Antazoline—HRH1—GPCRs, Class A Rhodopsin-like—EDNRB—asthma	0.000378	0.00351	CbGpPWpGaD
Antazoline—HRH1—GPCRs, Class A Rhodopsin-like—CXCR3—asthma	0.000367	0.00341	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR3—asthma	0.00036	0.00334	CbGpPWpGaD
Antazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—asthma	0.000353	0.00328	CbGpPWpGaD
Antazoline—HRH1—G alpha (q) signalling events—ITPR1—asthma	0.000352	0.00327	CbGpPWpGaD
Antazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—asthma	0.000351	0.00326	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—NPY—asthma	0.000351	0.00325	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—CYSLTR1—asthma	0.000348	0.00323	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—AGTR2—asthma	0.000338	0.00314	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—UTS2—asthma	0.000336	0.00312	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—CCL11—asthma	0.000336	0.00312	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—C5AR1—asthma	0.000336	0.00312	CbGpPWpGaD
Antazoline—HRH1—GPCRs, Class A Rhodopsin-like—BDKRB2—asthma	0.000336	0.00312	CbGpPWpGaD
Antazoline—HRH1—G alpha (q) signalling events—EDN1—asthma	0.000333	0.00309	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—EDNRB—asthma	0.000324	0.00301	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—CCR4—asthma	0.000322	0.00299	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—NPS—asthma	0.000321	0.00298	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—TAC1—asthma	0.000321	0.00298	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—C3AR1—asthma	0.000317	0.00294	CbGpPWpGaD
Antazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—ITPR1—asthma	0.000315	0.00293	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCR3—asthma	0.000314	0.00292	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CYSLTR2—asthma	0.000305	0.00283	CbGpPWpGaD
Antazoline—HRH1—GPCRs, Class A Rhodopsin-like—AGTR1—asthma	0.000304	0.00282	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—C5—asthma	0.0003	0.00278	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—TACR1—asthma	0.0003	0.00278	CbGpPWpGaD
Antazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—asthma	0.000298	0.00276	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—PTGDR—asthma	0.000295	0.00274	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—LTB4R—asthma	0.000295	0.00274	CbGpPWpGaD
Antazoline—HRH1—GPCRs, Class A Rhodopsin-like—ADRB2—asthma	0.000288	0.00267	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—C3AR1—asthma	0.000288	0.00267	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—BDKRB2—asthma	0.000288	0.00267	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CYSLTR2—asthma	0.000277	0.00257	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—CCR3—asthma	0.000274	0.00254	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CCL22—asthma	0.000268	0.00248	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—PTGDR—asthma	0.000268	0.00248	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—LTB4R—asthma	0.000268	0.00248	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—NPY—asthma	0.000267	0.00248	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—KNG1—asthma	0.000262	0.00243	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—AGTR1—asthma	0.00026	0.00241	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—AGTR2—asthma	0.000258	0.00239	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL10—asthma	0.000254	0.00236	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—HRH4—asthma	0.000251	0.00233	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—PMCH—asthma	0.000251	0.00233	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—PTGDR2—asthma	0.000251	0.00233	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—NPSR1—asthma	0.000251	0.00233	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB2—asthma	0.000247	0.00229	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—EDNRB—asthma	0.000247	0.00229	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CSF2RB—asthma	0.000245	0.00228	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—NPS—asthma	0.000244	0.00227	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—TAC1—asthma	0.000244	0.00227	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—TACR2—asthma	0.00024	0.00223	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CCR8—asthma	0.00024	0.00223	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—CXCR3—asthma	0.000239	0.00222	CbGpPWpGaD
Antazoline—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—asthma	0.00023	0.00214	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—PTGDR2—asthma	0.000228	0.00211	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—HRH4—asthma	0.000228	0.00211	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—NPSR1—asthma	0.000228	0.00211	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—PMCH—asthma	0.000228	0.00211	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CSF2RB—asthma	0.000223	0.00207	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—EDN1—asthma	0.00022	0.00205	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—BDKRB2—asthma	0.000219	0.00203	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL5—asthma	0.000219	0.00203	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—TACR2—asthma	0.000218	0.00203	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CCR8—asthma	0.000218	0.00203	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CCL17—asthma	0.000214	0.00199	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—PDE4A—asthma	0.00021	0.00195	CbGpPWpGaD
Antazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—asthma	0.000203	0.00188	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—KNG1—asthma	0.000199	0.00185	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—AGTR1—asthma	0.000198	0.00184	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—asthma	0.000197	0.00183	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CYSLTR1—asthma	0.000197	0.00183	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—CXCL10—asthma	0.000194	0.0018	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—C3—asthma	0.000193	0.00179	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—PDE4A—asthma	0.000191	0.00177	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—VIP—asthma	0.00019	0.00176	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—C5AR1—asthma	0.00019	0.00176	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—UTS2—asthma	0.00019	0.00176	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—ADRB2—asthma	0.000188	0.00174	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CCR4—asthma	0.000182	0.00169	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CYSLTR1—asthma	0.000179	0.00166	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—IL2RB—asthma	0.000175	0.00163	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—PDE4D—asthma	0.000174	0.00161	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CCL11—asthma	0.000172	0.0016	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—VIP—asthma	0.000172	0.0016	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—C5AR1—asthma	0.000172	0.0016	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—UTS2—asthma	0.000172	0.0016	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—FCER2—asthma	0.00017	0.00158	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—C3AR1—asthma	0.00017	0.00158	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—PDE4B—asthma	0.000169	0.00157	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—C5—asthma	0.000169	0.00157	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—TACR1—asthma	0.000169	0.00157	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—EDN1—asthma	0.000168	0.00156	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—CCL5—asthma	0.000167	0.00155	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CCR4—asthma	0.000165	0.00153	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CYSLTR2—asthma	0.000164	0.00152	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—IL2RB—asthma	0.000159	0.00148	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PTGDR—asthma	0.000158	0.00147	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CCL22—asthma	0.000158	0.00147	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—LTB4R—asthma	0.000158	0.00147	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—PDE4D—asthma	0.000158	0.00146	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CCR3—asthma	0.000155	0.00144	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—asthma	0.000154	0.00143	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—C5—asthma	0.000154	0.00143	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—PDE4B—asthma	0.000154	0.00143	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—TACR1—asthma	0.000154	0.00143	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—NPY—asthma	0.000151	0.0014	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—asthma	0.000151	0.0014	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—CCR5—asthma	0.00015	0.00139	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—C3—asthma	0.000147	0.00136	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—AGTR2—asthma	0.000146	0.00135	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CCR3—asthma	0.000141	0.00131	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—EDNRB—asthma	0.000139	0.00129	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—TAC1—asthma	0.000138	0.00128	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—NPS—asthma	0.000138	0.00128	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—NPY—asthma	0.000137	0.00127	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CXCR3—asthma	0.000135	0.00126	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—HRH4—asthma	0.000134	0.00125	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PMCH—asthma	0.000134	0.00125	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—NPSR1—asthma	0.000134	0.00125	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PTGDR2—asthma	0.000134	0.00125	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—AGTR2—asthma	0.000132	0.00123	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CSF2RB—asthma	0.000132	0.00122	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CCR8—asthma	0.000129	0.0012	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—TACR2—asthma	0.000129	0.0012	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—IL5—asthma	0.000128	0.00119	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—EDNRB—asthma	0.000127	0.00118	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CCL17—asthma	0.000126	0.00117	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—NPS—asthma	0.000125	0.00116	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—TAC1—asthma	0.000125	0.00116	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—BDKRB2—asthma	0.000124	0.00115	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CXCR3—asthma	0.000123	0.00114	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—ADCY2—asthma	0.00012	0.00111	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—IL3—asthma	0.000119	0.00111	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—asthma	0.000119	0.00111	CbGpPWpGaD
Antazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—asthma	0.000118	0.00109	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—POMC—asthma	0.000117	0.00109	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—IL5—asthma	0.000116	0.00108	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—CCL2—asthma	0.000115	0.00107	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—KIF3A—asthma	0.000113	0.00105	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PDE4A—asthma	0.000113	0.00105	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—KNG1—asthma	0.000113	0.00105	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—BDKRB2—asthma	0.000112	0.00104	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—AGTR1—asthma	0.000112	0.00104	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CXCL10—asthma	0.000109	0.00102	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—ADCY2—asthma	0.000109	0.00101	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—IL3—asthma	0.000108	0.00101	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—ADRB2—asthma	0.000106	0.000986	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CYSLTR1—asthma	0.000105	0.000979	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—KNG1—asthma	0.000102	0.000949	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CMA1—asthma	0.000102	0.000946	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—UTS2—asthma	0.000102	0.000946	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—C5AR1—asthma	0.000102	0.000946	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CCL11—asthma	0.000102	0.000946	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—VIP—asthma	0.000102	0.000946	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—AGTR1—asthma	0.000102	0.000944	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—ITPR1—asthma	0.0001	0.000932	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CXCL10—asthma	9.93e-05	0.000922	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CCR4—asthma	9.77e-05	0.000907	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—ADRB2—asthma	9.64e-05	0.000895	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—STAT6—asthma	9.58e-05	0.000889	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—EDN1—asthma	9.49e-05	0.000881	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CCL5—asthma	9.41e-05	0.000874	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—IL2RB—asthma	9.4e-05	0.000873	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PDE4D—asthma	9.32e-05	0.000865	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CSF2—asthma	9.27e-05	0.000861	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—ITPR1—asthma	9.12e-05	0.000847	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—C5—asthma	9.08e-05	0.000843	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PDE4B—asthma	9.08e-05	0.000843	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—TACR1—asthma	9.08e-05	0.000843	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—CXCL8—asthma	9.07e-05	0.000842	CbGpPWpGaD
Antazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—asthma	9.04e-05	0.000839	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—EDN1—asthma	8.62e-05	0.0008	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CCL5—asthma	8.55e-05	0.000794	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—PLA2G4A—asthma	8.52e-05	0.000791	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CCR5—asthma	8.48e-05	0.000787	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CSF2—asthma	8.42e-05	0.000782	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—IL2RA—asthma	8.36e-05	0.000776	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CCR3—asthma	8.3e-05	0.000771	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—C3—asthma	8.29e-05	0.00077	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—NPY—asthma	8.09e-05	0.000751	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—PPP2CA—asthma	7.84e-05	0.000728	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—AGTR2—asthma	7.81e-05	0.000725	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CCR5—asthma	7.7e-05	0.000715	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—IL2RA—asthma	7.59e-05	0.000705	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—C3—asthma	7.53e-05	0.000699	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—EDNRB—asthma	7.48e-05	0.000694	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—NPS—asthma	7.4e-05	0.000687	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—TAC1—asthma	7.4e-05	0.000687	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CXCR3—asthma	7.26e-05	0.000674	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CYBA—asthma	7.03e-05	0.000653	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PARP1—asthma	6.88e-05	0.000639	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—IL5—asthma	6.88e-05	0.000639	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—BDKRB2—asthma	6.64e-05	0.000616	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—POMC—asthma	6.63e-05	0.000615	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ADCY2—asthma	6.42e-05	0.000596	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—IL3—asthma	6.4e-05	0.000594	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—KNG1—asthma	6.04e-05	0.000561	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—POMC—asthma	6.02e-05	0.000559	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—AGTR1—asthma	6e-05	0.000557	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CCL2—asthma	5.89e-05	0.000547	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—IL6R—asthma	5.87e-05	0.000545	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CXCL10—asthma	5.87e-05	0.000545	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—RHOA—asthma	5.84e-05	0.000542	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—NTRK1—asthma	5.76e-05	0.000534	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ADRB2—asthma	5.7e-05	0.000529	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ITPR1—asthma	5.39e-05	0.0005	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—RHOA—asthma	5.3e-05	0.000492	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CD86—asthma	5.13e-05	0.000476	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CXCL8—asthma	5.13e-05	0.000476	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—EDN1—asthma	5.09e-05	0.000473	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CCL5—asthma	5.05e-05	0.000469	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PLA2G4A—asthma	5.03e-05	0.000467	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CSF2—asthma	4.97e-05	0.000462	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—IL2—asthma	4.9e-05	0.000455	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—SMAD3—asthma	4.84e-05	0.00045	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CXCL8—asthma	4.66e-05	0.000432	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PPP2CA—asthma	4.63e-05	0.00043	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CCR5—asthma	4.55e-05	0.000422	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—IL2RA—asthma	4.48e-05	0.000416	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—IL2—asthma	4.45e-05	0.000413	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—C3—asthma	4.45e-05	0.000413	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PDGFB—asthma	4.33e-05	0.000402	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—LEP—asthma	4.14e-05	0.000384	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—FN1—asthma	3.9e-05	0.000362	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—POMC—asthma	3.56e-05	0.00033	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CCL2—asthma	3.48e-05	0.000323	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—IL6R—asthma	3.47e-05	0.000322	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—EGFR—asthma	3.4e-05	0.000316	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—SERPINE1—asthma	3.25e-05	0.000302	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—RHOA—asthma	3.13e-05	0.000291	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—NOS3—asthma	3.1e-05	0.000288	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CXCL8—asthma	2.75e-05	0.000255	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—IL2—asthma	2.63e-05	0.000244	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—IL6—asthma	2.62e-05	0.000243	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—MMP9—asthma	2.49e-05	0.000231	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PTEN—asthma	2.47e-05	0.00023	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—VEGFA—asthma	2.23e-05	0.000207	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—STAT3—asthma	2.21e-05	0.000205	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—TGFB1—asthma	2.05e-05	0.00019	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—EGFR—asthma	2.01e-05	0.000187	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—IL6—asthma	1.55e-05	0.000143	CbGpPWpGaD
